986 studies found for:    "Hodgkin Disease"
Show Display Options
Rank Status Study
1 Completed Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
Conditions: Hodgkin Lymphoma;   Hodgkin Disease
Intervention: Drug: triptorelin
2 Completed Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
Conditions: Lymphoma, Hodgkin Disease;   Lymphoma;   Hodgkin Disease;   Lymphoma: Hodgkin
Interventions: Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cyclophosphamide;   Procedure: Autologous hematopoietic stem cell transplantation.
3 Completed Mantle Irradiation for Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Procedure: Mantle irradiation
4 Completed Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
Conditions: Hodgkin's Disease;   Lymphoma
Intervention:
5 Unknown  Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: R-mabHD;   Drug: ABVD
6 Recruiting Breast-Sparing Proton Therapy for Hodgkin's Disease
Condition: Hodgkins Disease
Intervention: Radiation: Proton
7 Completed Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
Conditions: Hodgkin's Disease;   Breast Cancer
Intervention: Drug: Tamoxifen
8 Recruiting Personalised Program for Women Treated for Hodgkin Disease
Conditions: Hodgkin Disease;   Breast Cancer
Intervention: Procedure: intensive screening
9 Completed Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Conditions: HIV Infections;   Hodgkin's Disease
Interventions: Drug: Vinblastine sulfate;   Drug: Dacarbazine;   Drug: Filgrastim;   Drug: Bleomycin sulfate;   Drug: Doxorubicin hydrochloride
10 Terminated Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
Conditions: B-Cell Lymphoma;   Hodgkin's Disease
Intervention: Drug: Thalidomide
11 Recruiting Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: Gemcitabine;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Antithymocyte Globulin;   Procedure: Allogeneic Stem Cell Infusion;   Drug: Tacrolimus;   Drug: Filgrastim (G-CSF);   Drug: Methotrexate
12 Active, not recruiting Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
Conditions: Lymphoma;   Hodgkin's Disease
Interventions: Drug: Melphalan;   Drug: Ara-C;   Drug: VP-16;   Drug: BCNU;   Drug: Rituxan;   Drug: Stem Cells
13 Completed Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)
Condition: Hodgkin's Disease
Interventions: Drug: Methotrexate;   Drug: Leucovorin calcium;   Drug: 6-Thioguanine
14 Active, not recruiting Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
Conditions: Lymphoma, Hodgkin Disease;   Lymphoma;   Hodgkin Disease;   Lymphoma: Hodgkin
Interventions: Drug: bleomycin;   Drug: cyclophosphamide;   Drug: prednisone;   Drug: vincristine;   Drug: Adriamycin;   Drug: Velban;   Drug: VP-16
15 Completed Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
Conditions: Hodgkin's Disease;   Malignant Lymphomas High Grade;   Chemoresistance
Intervention: Procedure: TEP au MIBI
16 Completed
Has Results
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: G-CSF Plus Plerixafor
17 Completed A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
Conditions: Pediatric;   Hodgkin's Disease
Interventions: Drug: COPP/ABV;   Drug: intensive chemo with concurrent growth factor
18 Terminated
Has Results
Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease
Conditions: Hodgkin's Disease;   Lymphoma
Intervention: Drug: Alemtuzumab (Campath-1H)
19 Completed A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: MDX-060
20 Recruiting Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Recurrent Adult Hodgkin Lymphoma
Interventions: Drug: gemcitabine hydrochloride;   Drug: bendamustine hydrochloride

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years